ArticleWorld journal of gastroenterology2010
Serologic and laboratory markers in prediction of the disease course in inflammatory bowel disease.
Article in World journal of gastroenterology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD-Disease Outcome and Response to Therapy.Journal of Crohn's & colitis · 2021Review
- The Role of Early Biologic Therapy in Inflammatory Bowel Disease.Inflammatory bowel diseases · 2019Review
- Dysregulation of innate immunity in ulcerative colitis patients who fail anti-tumor necrosis factor therapy.World journal of gastroenterology · 2016Observational
- Article
- Results of the first survey for the current status of inflammatory bowel disease management in Asian countries.Intestinal research · 2016Article
- Treatment of inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 2(nd) Asian Organization of Crohn's and Colitis (AOCC) meeting in Seoul.Intestinal research · 2016Article
- Risk assessment in Crohn's disease.Gastroenterology & hepatology · 2014Article
- In the pipeline.Gastroenterology & hepatology · 2014Article
- Characteristics of inflammatory bowel disease serology in patients with indeterminate colitis.Journal of clinical gastroenterology · 2014Observational
- Inflammatory bowel disease unclassified.Journal of Zhejiang University. Science. B · 2011Article
- Crohn's disease: the first visit.Gastroenterology & hepatology · 2011Article
- Prediction of disease course in inflammatory bowel diseases.World journal of gastroenterology · 2010Article
- New Trends in Inflammatory Bowel Disease.GE Portuguese journal of gastroenterologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The search for biologic markers that can assess the natural history and perhaps predict the course of individual's disease including response to treatments over time has become an important focus of inflammatory bowel disease research. The knowledge of an individual's prognosis can help physicians and patients make important management decisions and aid communication on risk and benefits of disease and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.